The Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) is a collaborative and cross-disciplinary initiative with a mission to deliver new and innovative solutions to combat AMR. Partnering Tufts Medical Center and Tufts University’s schools of Medicine, Veterinary Medicine, and Arts & Sciences (as well as members from Engineering, Nutrition, and Drug Development) under a single umbrella, CIMAR is uniquely poised to lead AMR research, drug discovery, patient care, and education. CIMAR believes that to effectively fight AMR, scientists must take a “One Health” approach to understanding disease transmission and the mechanisms by which we can stop it. One Health prioritizes the relationships among people, animals, the environment, and the foods we all consume as critical avenues by which drug-resistant microorganisms spread from one to another. Our team includes experts in fields critical to addressing AMR through One Health, including microbiology, infectious disease, veterinary medicine, engineering, epidemiology, global health, drug development, and policy. We believe that together we can preserve the effectiveness of existing antimicrobial drugs and establish a much-needed pipeline to develop new ones. Our Mission: Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness